BELLICUM PHARMACEUTICALS, INC Quarterly Nonoperating Income (Expense) in USD from Q1 2014 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q3 2023.
  • Bellicum Pharmaceuticals, Inc Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $10K.
  • Bellicum Pharmaceuticals, Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $1.45M, a 82.9% decline year-over-year.
  • Bellicum Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2022 was $2.01M, a 86.7% decline from 2021.
  • Bellicum Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2021 was $15.2M, a 65.5% decline from 2020.
  • Bellicum Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2020 was $44M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $1.45M $10K +$58K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.39M -$285K -$2.82M -111% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $4.21M $579K +$2.2M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.01M $1.15M -$6.49M -85% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $8.5M -$48K -$4.32M -101% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $12.8M $2.54M -$3.05M -54.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $15.9M -$1.62M +$708K +30.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $15.2M $7.63M -$24.2M -76% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $39.3M $4.28M -$7.14M -62.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $46.5M $5.59M +$37M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $9.44M -$2.33M -$34.5M -107% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $44M $31.8M +$46.9M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$2.91M $11.4M +$20M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$22.9M -$31.4M -$30.7M -3946% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $7.74M $32.2M +$32.9M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$25.1M -$15.1M -$14.4M -2209% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$10.7M -$8.6M -$8.02M -1400% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$2.66M -$777K -$169K -27.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$2.49M -$660K +$76K +10.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$2.57M -$653K +$1.82M +73.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$4.39M -$573K +$153K +21.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$4.54M -$608K +$61K +9.12% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$4.6M -$736K -$212K -40.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$4.39M -$2.47M -$2.05M -482% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$2.34M -$726K -$435K -149% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$1.91M -$669K -$419K -168% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$1.49M -$524K -$629K -599% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$861K -$425K -$582K -371% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 -$279K -$291K -$500K -239% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $221K -$250K -$421K -246% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $642K $105K +$55K +110% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $587K $157K +$25.1M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-13
Q3 2015 -$24.5M $209K +$1.41M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$25.9M $171K +$179K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$26.1M $50K +$63K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$26.1M -$24.9M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-13
Q3 2014 -$1.2M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$8K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$13K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.